MIDWEST HOLDING INC. FILES (8-K) Disclosing Other Events

Edgar Glimpses |


On June 30, 2014, Midwest Holding Inc. (the "Company") reconvened its annual meeting of shareholders for 2014 (the "Meeting") which had been adjourned on June 10, 2014 due to a lack of a quorum.

At the reconvened Meeting a quorum was achieved as a majority of the Company's outstanding shares of common stock were represented at the meeting, either in person or by proxy. A summary of the matters voted upon at the Meeting is set forth below.

(1) Election of Director: The nominees for election to the Board of Directors set forth below were elected by the shareholders by the following vote: Against and Authority Abstentions Broker Director Nominee For Withheld Non-Votes

Travis Meyer 86.99\% 13.01\% N/A N/A Rick D. Meyer 87.04\% 12.94\% N/A N/A Mark A. Oliver 87.88\% 12.12\% N/A N/A Milton Tenopir 87.54\% 12.46\% N/A N/A Jim Ballard 88.12\% 11.88\% N/A N/A Jack Theeler 88.33\% 11.67\% N/A N/A Les Meyer 87.08\% 12.92\% N/A N/A John R. Perkins 88.57\% 11.43\% N/A N/A

(2) Advisory Vote on the Compensation of our Named Executive Officers: The compensation of our named executive officers was approved by the shareholders by the following vote:

For Against Abstain Broker Non-Votes 75.46\% 12.48\% 12.06\% N/A

(3) Ratification of Appointment of Independent Registered Public Accounting Firm: The proposal to ratify the appointment of McGladrey LLP as our independent registered public accounting firm was approved by the shareholders by the following vote:

For Against Abstain Broker Non-Votes 87.62\% 2.18\% 9.20\% N/A


DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Symbol Name Price Change % Volume
UBMOF Ubm Plc Ord n/a n/a n/a 0



Symbol Last Price Change % Change










World Economic Forum at Davos 2019 - Frank Ricotta CEO BurstIQ

Matt Bird sits down with Frank Ricotta, CEO BurstIQ, at the World Economic Forum at Davos 2019

Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.